Hi

I need help with the assets/liabilities using the data chart below

As Reported Quarterly Balance Sheet
Report Date	10/01/2023
	3rd Quarter
Currency	USD
Audit Status	Unaudited
Consolidated	Yes
Scale	Thousands
Cash	$3,214,000.00
Money market funds	$3,503,000.00
Cash & cash equivalents	$19,728,000.00
Restricted cash	-
Marketable securities	$3,783,000.00
Accounts receivable, trade, gross	$14,958,000.00
Less: allowances	$160,000.00
Accounts receivable, trade	$14,798,000.00
Raw materials & supplies	$2,233,000.00
Goods in process	$1,961,000.00
Finished goods	$7,004,000.00
Inventories	$11,198,000.00
Prepaid expenses & other receivables	$4,196,000.00
Prepaid expenses & other current assets	-
Government securities and obligations	$4,728,000.00
Corporate debt securities	$44,000.00
Reverse repurchase agreements	$7,261,000.00
Time deposits	$748,000.00
Other Sovereign Securities	$2,000.00
Corporate debt securities	$78,000.00
Non-U.S. sovereign securities	$150,000.00
Total current assets	$53,703,000.00
Property, plant & equipment at cost	$45,626,000.00
Less: accumulated depreciation	$26,805,000.00
Property, plant & equipment, net	$18,821,000.00
Intangible assets, net	$35,021,000.00
Goodwill	$36,124,000.00
Deferred taxes on income	$9,259,000.00
Other assets	$13,133,000.00
Other Assets - Balancing value	$9,110,000.00
Equity investments	$4,023,000.00
Total assets	$166,061,000.00
Loans & notes payable	$2,000,000.00
Accounts payable	$8,355,000.00
Accrued liabilities	$10,101,000.00
Accrued rebates, returns & promotions	$15,808,000.00
Accrued compensation & employee related obligations	$3,337,000.00
Accrued taxes on income	-
Taxes on income	$2,899,000.00
Loans and Notes Payable Current portion	$1,870,000.00
Loans and Notes Payable	$3,870,000.00
Total current liabilities	$44,370,000.00
Notes	-
Debentures	-
Other long-term debt	-
Long-term debt	$26,051,000.00
Deferred taxes on income	$2,623,000.00
Employee related obligations	$5,687,000.00
Long-term taxes payable	$2,540,000.00
Other liabilities	$13,562,000.00
Total liabilities	$94,833,000.00
Common stock	$3,120,000.00
Foreign currency translation	-$7,376,000.00
Gain (loss) on securities	-$2,000.00
Employee benefit plans	-
Gain (loss) on derivatives & hedges	-$626,000.00
Pension liability adjustment	-$776,000.00
Accumulated other comprehensive income (loss)	-$8,780,000.00
Retained earnings & additional paid-in capital	-
Retained earnings (accumulated deficit)	$152,536,000.00
Less: common stock held in treasury, at cost	$75,648,000.00
Total Johnson & Johnson shareholders? equity	$71,228,000.00
Total equity	$71,228,000.00
Equity attributable to non-controlling interest	-
As Reported Quarterly Income Statement
Report Date	10/01/2023
	3rd Quarter
Currency	USD
Audit Status	Unaudited
Consolidated	Yes
Scale	Thousands
Sales to customers	$21,351,000.00
Cost of products sold	$6,606,000.00
Gross profit (loss)	$14,745,000.00
Selling, marketing & administrative expenses	$5,400,000.00
Research & development expense	$3,447,000.00
In-process research & development expenses	$206,000.00
Interest income	-
Interest expense, net of portion capitalized	$192,000.00
Other income (expense), net	-$499,000.00
Restructuring expenses	$158,000.00
Interest income	$374,000.00
Earnings (loss) before provision for taxes on income	$5,217,000.00
Provision for (benefit from) taxes on income	$908,000.00
Net earnings (loss)	$26,028,000.00
Weighted average shares outstanding - basic	$2,522,900.00
Weighted average shares outstanding - diluted	$2,549,700.00
Year end shares outstanding	$2,407,178.00
Net earnings (loss) per share from continuing operations - basic	$1.71
Net earnings (loss) per share from discontinued operations - basic	$8.61
Net earnings (loss) per share - basic	$10.32
Net earnings (loss) per share from continuing operations - diluted	$1.69
Net earnings (loss) per share from discontinued operations - diluted	$8.52
Net earnings (loss) per share - diluted	$10.21
Cash dividends per share	$1.19
Total revenues	$21,351,000.00
Net earnings from Discontinued Operations, net of tax	$21,719,000.00
Sale of Discontinued Operations before Tax - Gain/Loss	$21,202,000.00
Discontinued Operations - Tax Impacts - Gain/Loss on Sale	$517,000.00
As Reported Quarterly Cash Flow
Report Date	10/01/2023
	3rd Quarter
Currency	USD
Audit Status	Unaudited
Consolidated	Yes
Scale	Thousands
Net earnings (loss)	$31,104,000.00
Depreciation & amortization of property & intangibles	$5,643,000.00
Stock based compensation	$984,000.00
Asset write-downs	-
Net loss (gain) on sale of assets or businesses	-$117,000.00
Deferred tax provision (benefit)	-$1,782,000.00
Credit losses & accounts receivable allowances	-
Accounts receivable	-$851,000.00
Inventories	-$1,447,000.00
Accounts payable & accrued liabilities	$664,000.00
Other current & non-current assets	-$1,366,000.00
Other current & non-current liabilities	$2,260,000.00
Asset write	$820,000.00
Gain on Kenvue separation	-$20,984,000.00
Net cash flows from operating activities	$14,928,000.00
Additions to property, plant & equipment	-$2,954,000.00
Proceeds from the disposal of assets or businesses, net	$237,000.00
Acquisitions, net of cash acquired	-
Purchases of investments	-$9,981,000.00
Sales of investments	$15,787,000.00
Credit support agreements activity, net	-
Other investing activities	-$92,000.00
Other investing activities (primarily licenses & milestones)	-
Proceeds from credit support agreements	-$917,000.00
Net cash flows from investing activites	$2,080,000.00
Dividends to shareholders	-$8,905,000.00
Repurchase of common stock	-$4,838,000.00
Proceeds from short-term debt	$12,462,000.00
Repayment of short-term debt	-$21,645,000.00
Proceeds from long-term debt, net of issuance costs	$8,047,000.00
Repayment of long-term debt	-$502,000.00
Proceeds from the exercise of stock options	$907,000.00
Proceeds from the exercise of stock options or employee withholding tax on stock awards, net	-
Credit support agreements activity, net	$62,000.00
Proceeds from Kenvue, Inc. initial public offering	$4,241,000.00
Other financing activities	$115,000.00
Cash transferred to Kenvue at separation	-$1,114,000.00
Net cash flows from financing activities	-$11,170,000.00
Effect of exchange rate changes on cash & cash equivalents	-$237,000.00
Increase (decrease) in cash & cash equivalents	$5,601,000.00
Increase (decrease) in cash, cash equivalents & restricted cash	-
Cash & cash equivalents beginning of period	$14,127,000.00
Cash & cash equivalents, end of period	-
Cash, cash equivalents & restricted cash, end of period	$19,728,000.00

DEBT RATIO (Total Liabilities / Total Assets)

NET PROFIT MARGIN (Net Income / Total Revenue)

Total Liabilities

Net Income

Total Assets

Total Revenue

EARNINGS PER SHARE (Net Income / Weighted Average Common Shares Outstanding)

RETURN ON ASSETS (Net Income / Total Assets)

Net Income

Net Income

Shares Outstanding

Total Assets

PRICE EARNINGS RATIO (Share Price (end of quarter / EPS)

RETURN ON EQUITY (Net Income - Preferred Dividends / Shareholder's Equity)

Stock Price

NI - Pref. Div.

EPS

Shareholder's Equity